RecruitingNCT06206681
Efficacy and Safety of Ultrapulse Carbon Dioxide Laser Treatment in Eyelid Tumors
Sponsor
Sun Yat-sen University
Enrollment
1,000 participants
Start Date
Nov 1, 2022
Study Type
OBSERVATIONAL
Conditions
Summary
This study aims to assess the long-term efficacy and safety of ultrapulse carbon dioxide (CO₂) laser excision in the treatment of eyelid tumors, including xanthelasma, pigmented nevi, keratoses, and so on.
Eligibility
Min Age: 18 YearsMax Age: 80 Years
Inclusion Criteria3
- Clinically diagnosed with eyelid lesions, including xanthelasma, pigmented nevi, keratoses, and so on.
- No history of photosensitivity, bleeding, or coagulation disorders
- Willing to attend follow-up appointments as scheduled
Exclusion Criteria6
- Presence of infection in the target area
- Allergy to lidocaine
- Keloid-prone or poor skin repair ability
- Pregnant or lactating
- Recent history of severe infectious diseases, active skin diseases, or major diseases affecting the cardiovascular, liver, kidney, endocrine, and hematopoietic systems
- History of malignant tumors or immune system disorders
Interventions
PROCEDUREUltra-pulsed Carbon Dioxide Laser
Excision of eyelid lesion
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06206681